Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F George

Showing results (701-710 of 750) with videos related to

Pageof 75
Sort By:
Research Square|January 30, 2023
Spatiotemporal immune atlas of the first clinical-grade, gene-edited pig-to-human kidney xenotransplantMatthew D Cheung, Rebecca Asiimwe, Elise N Erman, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
Journal of Medicinal Chemistry|April 21, 2007
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimizationAndrew J Prongay, Zhuyan Guo, Nanhua Yao, et al.
Diabetes|October 9, 2008
Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetesStruan F A Grant, Hui-Qi Qu, Jonathan P Bradfield, et al.
Nature Communications|April 11, 2024
Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplantMatthew D Cheung, Rebecca Asiimwe, Elise N Erman, et al.
Nature Genetics|September 2, 2008
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel diseaseSubra Kugathasan, Robert N Baldassano, Jonathan P Bradfield, et al.
Immunity|March 21, 2026
Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV reboundTongcui Ma, Ashley F George, Zichong Li, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorAshok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Neurology. Genetics|August 20, 2016
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studiesMichaela F George, Farren B S Briggs, Xiaorong Shao, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitorsVinay M Girijavallabhan, Carmen Alvarez, Frank Bennett, et al.
Pageof 75

Showing results (701-710 of 750) with videos related to

Sort By:
Pageof 75
Research Square|January 30, 2023
Spatiotemporal immune atlas of the first clinical-grade, gene-edited pig-to-human kidney xenotransplantMatthew D Cheung, Rebecca Asiimwe, Elise N Erman, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
Journal of Medicinal Chemistry|April 21, 2007
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimizationAndrew J Prongay, Zhuyan Guo, Nanhua Yao, et al.
Diabetes|October 9, 2008
Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetesStruan F A Grant, Hui-Qi Qu, Jonathan P Bradfield, et al.
Nature Communications|April 11, 2024
Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplantMatthew D Cheung, Rebecca Asiimwe, Elise N Erman, et al.
Nature Genetics|September 2, 2008
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel diseaseSubra Kugathasan, Robert N Baldassano, Jonathan P Bradfield, et al.
Immunity|March 21, 2026
Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV reboundTongcui Ma, Ashley F George, Zichong Li, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorAshok Arasappan, Frank Bennett, Stephane L Bogen, et al.
Neurology. Genetics|August 20, 2016
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studiesMichaela F George, Farren B S Briggs, Xiaorong Shao, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitorsVinay M Girijavallabhan, Carmen Alvarez, Frank Bennett, et al.
Pageof 75